Celltrion Seo Jung-jin

Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...

Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...

Shinhan Financial Group appointed the head of its flagship banking unit as the group’s next chief executive officer as the major South Korean ...

As domestic budget carriers begin opening or resuming flights to Taipei, the skyways between Korea and Taiwan have widened further.Jeju Air announce...

Celltrion Inc. said it has confirmed the effectiveness and safety of Remsima SC in its third-phase global clinical trials, conducted on 438 patients...

South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...

"The Astronaut," the first solo album of K-pop megaband BTS member Jin, has sold over 1 million copies in the 16 days since its launch.Released on O...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund managing 917.2 trillion won ($692 billion) in asset...

South Korean biopharmaceutical giant Celltrion Inc. announced 654.6 billion won ($478.2 million) in revenue and 213.8 billion won in operating profi...

South Korea’s food manufacturing giant Ottogi Co. has selected Jin from K-pop band BTS as its new face of the uber-popular Jin Ramen line.&nbs...

Rising interest rates amid a slowing global economy rattled South Korean companies’ market capitalization rankings, bumping online players suc...

Members of K-pop boy band BTS will fulfill South Korea’s national military duty, starting with its oldest member Jin, their agency HYBE Co. an...

Celltrion Inc., South Korea’s biopharmaceutical giant, made a foray into the digital healthcare sector for its future growth by launching a sm...

Ottogi Co. is emerging as a formidable rival to Nongshim Co. in South Korea's instant noodle market, becoming the most popular ramen for the fifth w...

Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...

The issue of allowing K-pop megaband BTS to fulfill alternative service to active military duty resurfaced again on Thursday, with government offici...

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...

Korea Investment Corporation (KIC) said on Wednesday it has promoted Lee Hoon, its former head of investment strategy and innovation division, to th...

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...

The late Samsung Group chairman Lee Kun-hee was an avid arts collector.Though the business magnate did not mention names, it was easy to guess who h...

South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...

South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...

South Korea's biopharmaceutical company Celltrion Inc. plans to sell all of its biosimilar products through its own sales channels in Europe to impr...

Kim Jung-ju, the founder of global gaming giant Nexon Co. died in late February. He was 54.NXC Corp., the holding company of Nexon, announced on T...

South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...

EcoPro BM Co., a leading manufacturer of cathode material for secondary batteries, topped the market capitalization for Kosdaq-listed firms on Jan...

Netflix mega-hit Squid Game’s actor Oh Young-soo, Player 001, has won Best Performance by an Actor in a Supporting Role on TV at the 79th Gold...

Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...